Video-Guided Acupuncture Imagery for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer
Video-Guided Acupuncture Imagery Treatment (VGAIT)
Treatment Study
Summary
Study start date: January 6, 2026
Actual date on which the first participant was enrolled.The study aims to explore a new approach called Video-Guided Acupuncture Imagery Treatment (VGAIT) to help people with breast cancer who have ongoing problems with nerve pain or numbness after chemotherapy, known as chemotherapy-induced peripheral neuropathy (CIPN). This condition often affects patients' quality of life, and finding effective ways to manage it is important. The study targets individuals with stage I-III breast cancer who continue to experience these symptoms despite completing their chemotherapy. By investigating VGAIT, the study hopes to offer a potential new method to alleviate the discomfort associated with CIPN. Participants in the study will undergo 16 sessions of VGAIT over a period of 8 weeks, conducted remotely via Zoom. The treatment involves guided imagery, which is a technique that uses visualization to help manage pain and discomfort. Researchers will evaluate how well participants continue with the treatment, how satisfied they are with this new method, and whether they complete all the study assessments. These factors will help determine the feasibility of using VGAIT for managing CIPN. The study measures are taken at the beginning, halfway through, and at the end of the 8-week period to assess the progress and effectiveness of the treatment.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.20 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.From 18 to 80 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Massachusetts General Hospital
Charlestown, United StatesOpen Massachusetts General Hospital in Google Maps